CAMBRIDGE CANCER GENOMICS
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the time required to know whether treatment is working, buying the clinician more time to alter treatment and reduce unnecessary side effects. The technology can detect relapse earlier than standard of care, predict response to therapy, and decrease ineffective treatment regimens. Over time, CCG will be able to better predict the best therapeutic strategy for cancer patients before they even begin treatment. Cambridge Cancer Genomics was founded on 2016 and is headquartered in Cambridge, England.
CAMBRIDGE CANCER GENOMICS
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2016-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.ccg.ai
Total Employee:
11+
Status:
Active
Total Funding:
8.5 M USD
Technology used in webpage:
SPF Domain Not Resolving Euro Amazon Google Apps For Business Amazon S3 CDN AWS Global Accelerator
Current Advisors List
Advisor
2019-01-01
Current Employees Featured
Harry Clifford Co-Founder and Chief Technology Officer @ Cambridge Cancer Genomics
Co-Founder and Chief Technology Officer
2017-01-01
John Cassidy Co-Founder and CEO @ Cambridge Cancer Genomics
Co-Founder and CEO
2016-03-01
Nirmesh Patel Co-Founder and Chief Scientific Officer @ Cambridge Cancer Genomics
Co-Founder and Chief Scientific Officer
2016-03-01
Founder
Investors List
Soma Capital
Soma Capital investment in Seed Round - Cambridge Cancer Genomics
Refactor Capital
Refactor Capital investment in Seed Round - Cambridge Cancer Genomics
Romulus Capital
Romulus Capital investment in Seed Round - Cambridge Cancer Genomics
Y Combinator
Y Combinator investment in Seed Round - Cambridge Cancer Genomics
AME Cloud Ventures
AME Cloud Ventures investment in Seed Round - Cambridge Cancer Genomics
DTRIBE Capital
DTRIBE Capital investment in Seed Round - Cambridge Cancer Genomics
FundersClub
FundersClub investment in Seed Round - Cambridge Cancer Genomics
Y Combinator
Y Combinator investment in Seed Round - Cambridge Cancer Genomics
NewDo Venture
NewDo Venture investment in Seed Round - Cambridge Cancer Genomics
Endure Capital
Endure Capital investment in Seed Round - Cambridge Cancer Genomics
Newest Events participated
Official Site Inspections
http://www.ccg.ai
- Host name: ec2-52-20-84-62.compute-1.amazonaws.com
- IP address: 52.20.84.62
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Cambridge Cancer Genomics"
CCG.ai - F6S
Oncocross AI powered Drug Development, Biomarker & Cancer diagnostic platform OncoAI Artificial Intelligence for determining breast and lung cancer recurrence Mercurial AI AI …See details»
CCG.ai (acquired by Dante Labs) - LinkedIn
CCG.ai (acquired by Dante Labs) | 3,061 followers on LinkedIn. Data-Driven Cancer Treatment. CCG.ai | On a mission to ensure that each patient has the right drug, at the right time, to beat …See details»
Cambridge Cancer Genomics - Crunchbase Company Profile
Contact Email info@ccg.ai Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated. Using simple blood draws, CCG shortens the …See details»
Dante Labs acquires CCG.ai to build precision oncology software
Jun 25, 2021 CCG.ai was founded on the premise that every patient should be on the right treatment, at the right time, to beat their cancer. “Since that founding moment, the team has …See details»
Dante Labs acquires Cambridge Cancer Genomics to create
Jun 23, 2021 CCG.ai OncOS precision oncology software platform drives real life decisions to ensure data-driven cancer treatment for all patients. About CCG.ai Cambridge Cancer …See details»
Delivering the potential of cancer genomics to patients - nonacus
Jun 15, 2020 Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to …See details»
Company Information - RocketReach
Cambridge Cancer Genomics (CCG.ai) are on a mission to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven …See details»
Cambridge Cancer Genomics Inc. (CCG.ai) - life-sciences-europe.com
Jan 25, 2017 Recursion & Enamine Release AI-enabled Compound Libraries; Cepheid and Oxford Nanopore Technologies Partner; Matthias Evers Joins Indivumed as CBO from Evotec; …See details»
Cambridge Cancer Genomics (CCG.ai; acquired by Dante Labs)
Organization Website: ccg.ai : Contact Email: info@ccg.ai: Cambridge Cancer Gen... industries Biotech: Headquarters Location: Future Business Centre, Cambridge, Cambridgeshire, CB4 …See details»
Cambridge Cancer Genomics: CCG.ai empowers clinicians to make ...
CCG.ai exist to ensure that each patient has the right drug, at the right time, to beat their cancer. We build the software to enable data-driven precision oncology and systematically develop …See details»
Dante Labs acquires Cambridge Cancer Genomics to create global ...
Jun 23, 2021 CAMBRIDGE, United Kingdom, June 23, 2021 (GLOBE NEWSWIRE) -- Dante Labs, a leading genomics and diagnostics company, today announced the acquisition of …See details»
Canadian Coast Guard Integrated Business and Human Resource …
The organization attracts people who want to pursue a long-term, fulfilling career. ... Completion of an Artificial Intelligence (AI) readiness study involving multiple Coast Guard areas, designed to …See details»
Zero Trust by CCG | Phen Zero Trust | CheckMate Security Solution
CCG’s CheckMate and Phen.AI provide a humanoid AI-driven and controlled Insider Threat – User Entity Behavioral Analytics (IT-UEBA) security solution that plays a critical role in …See details»
Dante Labs, Cambridge Cancer Genomics, Nonacus Collaborate
Jun 15, 2020 NEW YORK ─ Dante Labs, Cambridge Cancer Genomics (CCG.ai), and Nonacus said on Monday that they have inked a collaboration agreement to build a high-throughput …See details»
The Importance of AI - CCG Catalyst
Jan 9, 2025 So whether an organization decides to fully look at its data and infrastructure or is simply exploring how the stores it has might help solve problems, data is the place to begin. ...See details»
CCG - Crunchbase Company Profile & Funding
CCG offers data and analytics solutions that empower you to make critical decisions for your business. ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Generative AI | CCG Accel – Powered by HKSTP - Chinachem Group
The focus of Cohort 3 of CCG Accel - Powered by HKSTP is generative AI solutions and the stage is the entire CCG business. These solutions are applied to both external and internal …See details»
Can AI safeguard us against AI? One of its Canadian pioneers
3 days ago The world's most cited AI researcher is launching a new research non-profit organization called LawZero to "look for scientific solutions to how we can design AI that will …See details»
Building an AI Organization Competency - Scaled Agile Framework
May 16, 2025 An AI organization uses AI not only to enhance internal productivity—automating routine tasks, surfacing insights, and accelerating decision-making—but also to enrich its …See details»
How CMOs Are Scaling GenAI in Turbulent Times | BCG
Jun 2, 2025 AI and GenAI remain at the top of the CMO agenda, even amid the latest wave of turbulence in global markets. According to our annual global survey of 200 CMOs, conducted …See details»